| # | Drug | Count |
|---|---|---|
| 0 | METOCLOPRAMIDE HYDROCHLORIDE | 76 |
| 1 | METOCLOPRAMIDE | 72 |
| 2 | FERRIC CARBOXYMALTOSE | 46 |
| 3 | FERRIC CARBOXYMALTOSE INJECTION | 46 |
| 4 | FINASTERIDE | 44 |
| 5 | ALPRAZOLAM | 42 |
| 6 | SIMVASTATIN | 40 |
| 7 | VARENICLINE TARTRATE | 35 |
| 8 | ASPIRIN | 34 |
| 9 | ASPIRIN 325 MG | 34 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ABACAVIR , LAMIVUDINE AND ZIDOVUDINE | 1 | 0.1000 |
| 1 | TAFENOQUINE | 2 | 0.0303 |
| 2 | QUINIDINE GLUCONATE | 1 | 0.0154 |
| 3 | L-PHENYLALANINE | 1 | 0.0127 |
| 4 | VARDENAFIL HYDROCHLORIDE | 1 | 0.0122 |
| 5 | MALATHION | 1 | 0.0099 |
| 6 | FERRIC CARBOXYMALTOSE | 46 | 0.0097 |
| 7 | ALUMINUM HYDROXIDE GEL | 1 | 0.0068 |
| 8 | MEFLOQUINE HYDROCHLORIDE | 1 | 0.0064 |
| 9 | ACAMPROSATE CALCIUM | 2 | 0.0060 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 112 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 75 |
| 2 | 5-alpha Reductase Inhibitor [EPC] | 46 |
| 3 | HMG-CoA Reductase Inhibitor [EPC] | 42 |
| 4 | Atypical Antipsychotic [EPC] | 36 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 36 |
| 6 | Progestin [EPC] | 35 |
| 7 | Cardiac Glycoside [EPC] | 32 |
| 8 | Proton Pump Inhibitor [EPC] | 30 |
| 9 | Anti-epileptic Agent [EPC] | 26 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Pyrethroid [EPC] | 2 | 0.0011 |
| 1 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 2 | Androgen [EPC] | 17 | 0.0006 |
| 3 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 4 | Ergot Derivative [EPC] | 3 | 0.0006 |
| 5 | 5-alpha Reductase Inhibitor [EPC] | 46 | 0.0004 |
| 6 | Cardiac Glycoside [EPC] | 32 | 0.0004 |
| 7 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 8 | Monoamine Oxidase Inhibitor [EPC] | 1 | 0.0003 |
| 9 | Adenosine Receptor Agonist [EPC] | 2 | 0.0003 |